Skip to main content
Skip to main navigation
Invalid credentials.
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical R&D
Biopharmaceutical Sales & Marketing
Biosimilars
Healthcare Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Cardiovascular
Central Nervous System
Diabetes & Endocrinology
Infectious Diseases
Internal Medicine
Oncology
Early Phase Oncology
Translational Oncology
Pediatrics
Public Health Interest
Vaccines
Other Therapeutic Areas
Our Focus
Our Values
Our Heritage
Our Perspectives
Our Leadership
Ethics & Compliance
Investors
Build brand value by promoting effective health management
In the face of healthcare complexity, knowledge is power. The more you educate your audiences about your product, the higher your chances of success.
Clinical Educator Programs
Quintiles has a solution to help deliver the critical information pharma provides and doctors and patients need. Read fact sheet
Improving Adherence
Overcome accessibility issues and limited resources to deliver ongoing education to healthcare professionals and encourage better adherence among patients. Read case study
A Patient Centric Focus
In this article explains how a patient-centric focus can be used to support delivery of brand strategy, innovative sales and marketing solutions, and market entry models. Read article
Payers are gaining a greater voice, and proving evidence of value starts with patient education.
Dedicated clinical educators can help improve patient outcomes – and build your brand. Read more
To increase patient adherence, we worked with over 600,000 diabetes patients and clinicians. Learn how
Understanding real-world patients is the key to more effective market access programs. Find out more
Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research Read more
Quintiles Announces Completion of Initial Public Offering of 27,236,841 Shares of Common Stock Read more
Quintiles Announces Pricing of Initial Public Offering Read more
Harnessing the Power of the Digital Patient White Paper Read more
Tomorrow’s Path to Improved Early-Phase Oncology Drug Development Read more
Strategic Portfolio Management & New Influencers in R&D Decision-Making Read more